| Financial Year |
March 31 2023 |
| Monetary Funds |
8,721,069,381.53 |
| Held-for-trading Financial Assets |
37,218,119.72 |
| Notes Receivable |
2,743,582,648.71 |
| Accounts Receivable |
15,539,493,005.13 |
| Advances to Suppliers |
1,912,003,426.16 |
| Other Receivables |
3,257,355,516.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,800,857,663.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
643,161,325.12 |
| Total Current Assets |
54,290,883,990.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
635,013,979.73 |
| Long-term Equity Investment |
5,324,808,362.61 |
| Investment Properties |
246,035,950.74 |
| Fixed Assetes |
27,995,408,272.58 |
| Under-construction Projects |
3,574,185,500.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
739,443,788.97 |
| R&D expenses |
-- |
| Goodwill |
140,941,639.57 |
| Long-Term Deferred and Prepaid Expenses |
229,085,234.88 |
| Deferred Income Tax Assets |
579,206,640.73 |
| Other Non-Current Assets |
2,059,731,705.87 |
| Sub-Total of Non-Current Assets |
45,527,317,001.70 |
| Total Assets |
99,818,200,991.75 |
| Short-Term Loans |
1,547,983,470.85 |
| Trading Financial liabilities |
2,563,364.78 |
| Notes Payable |
2,964,040,761.56 |
| Accounts Payable |
13,239,590,318.55 |
| Accounts Received In Advance |
23,070,573.72 |
| Employee Compensation Payable |
1,042,585,744.46 |
| Taxes Payable |
730,840,103.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,209,564,503.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,536,339,973.36 |
| Other Current Liabilities |
2,341,112,897.75 |
| Sub-Total of Current Liabilities |
35,047,689,161.25 |
| Long-term Loans |
14,672,058,090.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,207,615,954.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
235,150,658.59 |
| Deferred Income Tax Liabilities |
903,475,007.94 |
| Other Non-Current Liabilities |
150,982,335.29 |
| Sub-Total of Non-Current Liabilities |
21,636,659,395.28 |
| Total Liabilities |
56,684,348,556.53 |
| Paid-In Capital(Or Share Stock) |
2,149,973,551.00 |
| Capital Surplus |
13,516,578,546.07 |
| Surplus Reserve |
1,164,953,965.85 |
| LESS:Treasury Stock |
1,071,557,279.26 |
| Undistributed Profits |
22,091,261,019.32 |
| Minority Stockholder's Interest |
5,566,363,166.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
37,567,489,268.73 |
| Owner's Equity（Stockholder's Equity） |
43,133,852,435.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
99,818,200,991.75 |
